org placeholder image

Carl Klint

Clinical Trial Manager at Inhibikase Therapeutics

  • LinkedIn

Email Email: c****@apellis.com

phone noPhone Number: (***)-***-****

map
INHIBIKASE THERAPEUTICS

INHIBIKASE THERAPEUTICS

  • description Description
    Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's...

    Read More

  • Employees count Employees 1-10
  • Revenue Revenue 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Inhibikase Therapeutics Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Carl Klint

Answer: Carl Klint works for Inhibikase Therapeutics as Clinical Trial Manager

Answer: Carl Klint’s role in Inhibikase Therapeutics is Clinical Trial Manager

Answer: Carl Klint's email address is c***@gmail.com

Answer: Carl Klint's business email address is c****@apellis.com

Answer: Carl Klint’s direct phone number is (***)-***-****

Answer: Carl Klint works in the industry of: Pharmaceuticals

Answer: Carl Klint works Inhibikase Therapeutics located at 3350 Riverwood Pkwy Se Ste 1900, ATLANTA, Georgia, 30339, United States

Answer: Inhibikase Therapeutics's Clinical Trial Manager is Carl Klint

Answer: Carl Klint contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@apellis.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access